Enzychem Lifesciences Calls Temporary Shareholders Meeting to Elect New Directors and Amend Articles, Aiming to Restore Governance and Enter Real Estate Development
Following the resignation of an outside director in June which dropped the outside director ratio from 50% to 33%, Enzychem Lifesciences convenes a temporary shareholders meeting to elect three inside directors, two outside directors, and one auditor.
This move seeks to alleviate governance risks; after the election, the outside director ratio will rise to 40%, still below the previous 50% level.
The company proposes to amend its articles to add six new business purposes including land acquisition and development, modular home manufacturing, and temporary accommodation services, diversifying into real estate. It also deletes the clause on retirement compensation payment to reduce costs.
The new business lines lack clear synergy with the existing biotech core and involve no immediate capital commitment, limiting the near-term impact on shareholder value.
[AI Summary]Enzychem Lifesciences responds to recent governance concerns by bolstering its board through a temporary meeting and formalizing entry into new business areas. However, incomplete recovery of outside director ratio and unproven new ventures warrant careful investor monitoring.
KOSDAQ Filing Information
Resolution to Convene a General Meeting of Shareholders (Extraordinary General Meeting)